Watermark
  Back to Search Results

ZWI-ZW25-301

Active, not recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

ZWI-ZW25-301

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05152147

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2021-000296-36

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents